Ocugen pays USD 15 mn upfront to Bharat Biotech for Covaxin rights in Canada
Ocugen pays USD 15 mn upfront to Bharat Biotech for Covaxin rights in Canada Bharat Biotech on June 3 said it has agreed to expand the agreement with Ocugen Inc to commercialise the jab in Canada also. https://ift.tt/eA8V8J
Why Isn't There a Vaccine for the Common Cold? With more than 200 types of viruses causing colds, a vaccine targeting them all is a high bar to clear. The rhinovirus, which causes 50 to 75% of all colds, has more than a 100 different strains
Subscribe to:
Posts (Atom)
Subscribe UsPopular Posts
|